ACADIA Pharmaceuticals announces closing of public offering of common stock and options
ACADIA Pharma announced the closing of its underwritten public offering of 7,187,500 shares of its common stock, which includes 937,500 shares of common stock sold pursuant to the underwriters’ full exercise of their option. Gross proceeds are $287.5 million. September 20, 2019